Target Price | $39.27 |
Price | $27.23 |
Potential | 44.22% |
Number of Estimates | 21 |
21 Analysts have issued a price target Keurig Dr Pepper Inc 2026 . The average Keurig Dr Pepper Inc target price is $39.27. This is 44.22% higher than the current stock price. The highest price target is $46.20 69.67% , the lowest is $30.30 11.27% . | |
A rating was issued by 25 analysts: 16 Analysts recommend Keurig Dr Pepper Inc to buy, 9 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Keurig Dr Pepper Inc stock has an average upside potential 2026 of 44.22% . Most analysts recommend the Keurig Dr Pepper Inc stock at Purchase. |
22 Analysts have issued a sales forecast Keurig Dr Pepper Inc 2025 . The average Keurig Dr Pepper Inc sales estimate is $16.4b . This is 4.16% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $17.2b 9.17% , the lowest is $15.7b 0.21% .
This results in the following potential growth metrics:
2024 | $15.4b | 3.62% |
---|---|---|
2025 | $16.4b | 6.92% |
2026 | $17.1b | 4.17% |
2027 | $17.8b | 3.92% |
2028 | $24.9b | 40.34% |
2029 | $19.8b | 20.50% |
2030 | $20.8b | 4.72% |
2031 | $21.7b | 4.52% |
2032 | $22.7b | 4.40% |
17 Analysts have issued an Keurig Dr Pepper Inc EBITDA forecast 2025. The average Keurig Dr Pepper Inc EBITDA estimate is $4.9b . This is 36.26% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.2b 45.77% , the lowest is $4.4b 22.85% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $3.7b | 6.25% |
---|---|---|
2025 | $4.9b | 31.28% |
2026 | $5.1b | 5.16% |
2027 | $5.4b | 4.69% |
2028 | $5.8b | 7.38% |
2029 | $6.1b | 5.44% |
2030 | $6.2b | 1.18% |
2031 | $6.4b | 4.14% |
2032 | $6.7b | 3.88% |
2024 | 24.24% | 2.54% |
---|---|---|
2025 | 29.76% | 22.77% |
2026 | 30.04% | 0.94% |
2027 | 30.27% | 0.77% |
2028 | 23.16% | 23.49% |
2029 | 30.72% | 32.64% |
2030 | 29.68% | 3.39% |
2031 | 29.57% | 0.37% |
2032 | 29.42% | 0.51% |
24 Keurig Dr Pepper Inc Analysts have issued a net profit forecast 2025. The average Keurig Dr Pepper Inc net profit estimate is $2.8b . This is 82.77% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.0b 94.82% , the lowest is $2.7b 75.59% .
This results in the following potential growth metrics and future Net Margins:
2024 | $1.4b | 33.93% |
---|---|---|
2025 | $2.8b | 94.82% |
2026 | $3.0b | 6.45% |
2027 | $3.2b | 6.79% |
2028 | $3.5b | 8.11% |
2029 | $3.2b | 6.95% |
2030 | $3.5b | 8.97% |
2031 | $3.8b | 9.41% |
2032 | $4.1b | 8.24% |
2024 | 9.39% | 36.24% |
---|---|---|
2025 | 17.10% | 82.17% |
2026 | 17.48% | 2.22% |
2027 | 17.96% | 2.75% |
2028 | 13.84% | 22.94% |
2029 | 16.19% | 16.98% |
2030 | 16.85% | 4.08% |
2031 | 17.64% | 4.69% |
2032 | 18.29% | 3.68% |
24 Analysts have issued a Keurig Dr Pepper Inc forecast for earnings per share. The average Keurig Dr Pepper Inc EPS is $2.07 . This is 83.19% higher than earnings per share in the financial year 2024. The highest EPS forecast is $2.20 94.69% , the lowest is $1.99 76.11% .
This results in the following potential growth metrics and future valuations:
2024 | $1.05 | 32.26% |
---|---|---|
2025 | $2.07 | 97.14% |
2026 | $2.20 | 6.28% |
2027 | $2.35 | 6.82% |
2028 | $2.54 | 8.09% |
2029 | $2.36 | 7.09% |
2030 | $2.58 | 9.32% |
2031 | $2.82 | 9.30% |
2032 | $3.05 | 8.16% |
Current | 24.10 | 4.60% |
---|---|---|
2025 | 13.18 | 45.31% |
2026 | 12.38 | 6.07% |
2027 | 11.59 | 6.38% |
2028 | 10.72 | 7.51% |
2029 | 11.52 | 7.46% |
2030 | 10.57 | 8.25% |
2031 | 9.66 | 8.61% |
2032 | 8.93 | 7.56% |
Based on analysts' sales estimates for 2025, the Keurig Dr Pepper Inc stock is valued at an EV/Sales of 3.24 and an P/S ratio of 2.25 .
This results in the following potential growth metrics and future valuations:
Current | 3.38 | 21.94% |
---|---|---|
2025 | 3.24 | 4.04% |
2026 | 3.11 | 4.00% |
2027 | 3.00 | 3.77% |
2028 | 2.14 | 28.74% |
2029 | 2.69 | 25.78% |
2030 | 2.56 | 4.51% |
2031 | 2.45 | 4.33% |
2032 | 2.35 | 4.21% |
Current | 2.35 | 29.27% |
---|---|---|
2025 | 2.25 | 3.99% |
2026 | 2.16 | 4.00% |
2027 | 2.08 | 3.77% |
2028 | 1.48 | 28.74% |
2029 | 1.87 | 25.78% |
2030 | 1.78 | 4.51% |
2031 | 1.70 | 4.33% |
2032 | 1.63 | 4.22% |
Keurig Dr Pepper Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Buy
➜
Buy
|
Unchanged | Aug 27 2025 |
Deutsche Bank |
Buy
➜
Buy
|
Unchanged | Aug 26 2025 |
HSBC |
Buy
➜
Hold
|
Downgrade | Aug 26 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Jul 28 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Jul 17 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jul 17 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Jun 27 2025 |
Analyst Rating | Date |
---|---|
Unchanged
UBS:
Buy
➜
Buy
|
Aug 27 2025 |
Unchanged
Deutsche Bank:
Buy
➜
Buy
|
Aug 26 2025 |
Downgrade
HSBC:
Buy
➜
Hold
|
Aug 26 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jul 28 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Jul 17 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jul 17 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jun 27 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.